Results from the INSTEAD-XL trial have shown that thoracic endovascular aortic repair plus optimal medical treatment improves 5-year aorta-specific survival and delayed disease progression in patients ...

Contrary to previous research, racial minorities and patients with lower socioeconomic status are more likely to receive thoracic endovascular aortic repair (TEVAR) than open surgery, according to ...

Patients with acute, complicated type B aortic dissections can safely benefit from thoracic endovascular aortic repair (TEVAR) with a novel stent graft, according to a study presented January 27, 2014 ...

Thoracic endovascular aortic repair (TEVAR) confers a survival rate superior to that of open surgical repair of intact descending thoracic aortic aneurysms, a new study suggests. A team of ...

W.L. Gore and Associates announced it has received FDA approval for a thoracic stent graft with a new delivery system used for thoracic endovascular aortic repair procedures. The stent graft and ...

Thoracic endovascular aortic repair (TEVAR) effectively treats blunt traumatic aortic injury (BTAI), with acceptable long-term survival, low reintervention rates, and early diagnosis of manageable ...